Abstract:Objective
Oxidative stress and oxidized high-density lipoprotein (oxHDL) are implicated as risk factors for cardiovascular disease (CVD) in systemic lupus erythematosus (SLE). Yet, how HDL is oxidized and rendered dysfunctional in SLE remains unclear. Neutrophil extracellular traps (NETs), which are elevated in lupus, possess oxidant-generating enzymes including myeloperoxidase (MPO), NADPH oxidase (NOX) and nitric oxide synthase (NOS). We hypothesized that NETs mediate HDL oxidation, impairing cholesterol eff… Show more
“…Indeed, it has been shown that myeloperoxidase, lactoperoxidase, and eosinophil peroxidase have a central role in oxidative damage associated with inflammatory disorders by utilizing hydrogen peroxide and halides/pseudo halides to generate the corresponding hypohalous acid [31]. NETs have been reported to contain oxidative enzymes, including myeloperoxidase, NADPH oxidase, and nitric oxide synthase [32]. Therefore, the inhibitory effect of PDTC on IFN-gamma production by monocytes may be related to both its role as a low molecular weight thiol antioxidant and its potent inhibition of NF-kB.…”
“…Indeed, it has been shown that myeloperoxidase, lactoperoxidase, and eosinophil peroxidase have a central role in oxidative damage associated with inflammatory disorders by utilizing hydrogen peroxide and halides/pseudo halides to generate the corresponding hypohalous acid [31]. NETs have been reported to contain oxidative enzymes, including myeloperoxidase, NADPH oxidase, and nitric oxide synthase [32]. Therefore, the inhibitory effect of PDTC on IFN-gamma production by monocytes may be related to both its role as a low molecular weight thiol antioxidant and its potent inhibition of NF-kB.…”
“…Human neutrophils and monocytes were isolated by buoyant density centrifugation as described previously (21)(22)(23)(24)(25). The human monocytes were purified by adhesion, cultured in 35-mm plastic dishes (2 3 10 6 cells/dish; BD Biosciences, San Jose, CA), and incubated in 2 mM L-glutamine supplemented RPMI-1640 without phenol red (Life Technology, Carlsbad, CA).…”
Rationale: Interstitial lung diseases (ILDs) are associated with oxidative stress. Plasma biomarkers that are directly linked to oxidative stress responses in this disease have not been identified. Stable oxidation products of tyrosine residues in proteins may reflect the oxidative microenvironment in the lung or a systemic inflammatory state.Objectives: To determine if levels of protein tyrosine oxidation are elevated in plasma of patients with ILD compared with an age-and sex-matched healthy control cohort.Methods: Three tyrosine oxidation products (3-chlorotyrosine, 3-nitrotyrosine, and o,o9-dityrosine) were quantified by tandem mass spectrometry in cellular models, a mouse model of injuryinduced fibrosis, and in plasma of healthy control subjects and patients with ILD (n = 42 in each group).Measurements and Main Results: Plasma levels of 3-chlorotyrosine, 3-nitrotyrosine, and o,o9-dityrosine were markedly elevated in patients with ILD compared with control subjects with receiver operating characteristic curves separating these groups of 0.872, 0.893, and 0.997, respectively. In a murine model of lung fibrosis, levels of all three oxidative tyrosine modifications were increased in plasma and lung tissue. Cellular models support a critical role for a heme peroxidase and enzymatic sources of reactive oxygen species in the generation of these oxidized products.Conclusions: We demonstrate an increase in oxidized tyrosine moieties within proteins in the circulating plasma of patients with ILD. These data support the potential for development of oxidative stress-related biomarkers in early diagnosis, prognostication, and/or in evaluating responsiveness to emerging therapies for ILD.
“…When HDL becomes oxidised, it loses its cardioprotective effects and displays impaired cholesterol efflux capacity and decreased ability to block low-density lipoprotein (LDL) oxidation 4–10. We recently demonstrated that neutrophil extracellular traps in lupus promote proatherogenic modifications (3-nitrotyrosine and 3-chlorotyrosine oxidation) in HDL and that oxidised lupus HDL displays impaired cholesterol efflux capacity 7. What remains unclear is whether this modified SLE HDL promotes aberrant myeloid cell responses, leading to atherogenesis and systemic inflammation.…”
Objectives-
Recent evidence indicates that high-density lipoprotein (HDL) exerts vasculoprotective activities by promoting activating transcription factor 3 (ATF3), leading to down-regulation of TLR-induced inflammatory responses. Systemic lupus erythematosus (SLE) is associated with increased cardiovascular disease (CVD) risk not explained by the Framingham risk score. Recent studies have indicated oxidized HDL as a possible contributor. We investigated the potential mechanisms by which lupus HDL may lose its anti-inflammatory effects and promote immune dysregulation.
Methods-
Control macrophages were challenged with control and SLE HDL in vitro and examined for inflammatory markers by real time qRT-PCR, confocal microscopy, ELISA and flow cytometry. Lupus prone mice were treated with an HDL mimetic (ETC-642) in vivo and inflammatory cytokine levels measured by real time qRT-PCR and ELISA.
Results-
Compared to control HDL, SLE HDL activates NFκB, promotes inflammatory cytokine production, and fails to block TLR-induced inflammation in control macrophages. This failure of lupus HDL to block inflammatory responses is due to an impaired ability to promote ATF3 synthesis and nuclear translocation. This inflammation is dependent on lectin-like oxidized low-density lipoprotein receptor 1 (LOX1R) binding and ROCK1/2 kinase activity. HDL mimetic-treated lupus mice showed significant ATF3 induction and pro-inflammatory cytokine abrogation.
Conclusions-
Lupus HDL promotes pro-inflammatory responses through NFκB activation and decreased ATF3 synthesis and activity in a LOX1R- and ROCK1/2-dependent manner. HDL mimetics should be explored as potential therapies for inflammation and SLE cardiovascular risk.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.